Erythropoietin for the treatment of anemia in patients with hematologic disorders

This article introduces common data and our experience concerning the treatment with recombinant human erythropoietin anemia (r-HuEPO) in anemic patients with different disorders. We cited as an example some results of Eprex (Janssen-Cilag) therapy for patients with hematologic disorders in Russia....

Full description

Bibliographic Details
Main Authors: R. A. Podgurskaya, V. V. Pshibieva
Format: Article
Language:Russian
Published: ABV-press 2022-11-01
Series:Онкогематология
Subjects:
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/642